N'-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-3,4-dimethoxybenzimidamide as an antimicrobial compound

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11912675
SERIAL NO

18378750

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-3,4-dimethoxybenzimidamide compound, its synthesis, and its use as an antimicrobial agent.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • KING FAISAL UNIVERSITY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ahmed, Antar Ahmed Abdelhamid Al-Ahsa, SA 143 3
Ahmed, Hany Mohamed Abd El-Lateef Al-Ahsa, SA 170 2
Ali, Mai Mostafa Khalaf Al-Ahsa, SA 190 4
Amer, Amer A Al-Ahsa, SA 126 35

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Aug 27, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 27, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 27, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00